BELVIQ

This brand name is authorized in Brazil, United States

Active ingredients

The drug BELVIQ contains one active pharmaceutical ingredient (API):

1 Lorcaserin
UNII REV26SR2B4 - LORCASERIN HYDROCHLORIDE HEMIHYDRATE

Lorcaserin is believed to decrease food consumption and promote satiety by selectively activating 5-HT2C receptors on anorexigenic pro-opiomelanocortin neurons located in the hypothalamus. The exact mechanism of action is not known. It is used as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients.

Read about Lorcaserin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
BELVIQ / BELVIQ XR Film-coated tablet / Extended-release tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A08AA11 A Alimentary tract and metabolism → A08 Antiobesity preparations, excl. diet products → A08A Antiobesity preparations, excl. diet products → A08AA Centrally acting antiobesity products
Discover more medicines within A08AA11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Cรขmara de Regulaรงรฃo do Mercado de Medicamentos Identifier(s): 508020050130617, 508020050130717, 508020050130817, 508020050130917
Country: US FDA, National Drug Code Identifier(s): 62856-529, 62856-535

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.